Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Blocking IL-8 can reduce skin rashes from cancer treatment.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia areata involves immune response and gene changes affecting hair loss.

Skin lymphatic vessels are essential for hair growth.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Animal models are crucial for learning about hair loss and finding treatments.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

3D cell-derived matrices improve tissue regeneration and disease modeling.